NL-OMON47526
Completed
Phase 4
T-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease a prospective randomized trial<br> - Prevention of cardiac events by T2DM patients
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- diabetes cardiac disease
- Sponsor
- Medical university of Vienna
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type\-2 diabetes mellitus for at least six months
- •\>18 years of age men or female
- •written informed consent to participate in the study and ability to comply with
- •all requirements
Exclusion Criteria
- •maximum dose of RAS\-antagonists or beta\-blocker
- •symptomatic hypotension and/or systolic blood pressure \< 100 mgHG at visit 1
- •symptomatic bradycardia and/or heart rate \< 60 bpm at visit 1
- •history of hypersensivity to any of the drugs investigated as well as known or
- •suspected contraindications to the study drug of previous history of
- •intolerance to high dose of RAAS antagonists or beta\-blocker in the absence of
- •any other bloddpressure lowering drugs
- •Creatinin \> 2\.5 mg/dl
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-NLMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-ATMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-ESMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease.EUCTR2015-000239-34-GBMedical University of Vienna2,400
Completed
Not Applicable
The BNP Assisted Teatment to Lessen Serial Cardiac Readmissions and Death.Heart FailureCardiovascular - Other cardiovascular diseasesACTRN12605000735651Health Research Council of New Zealand363